Scalable and Cost-Effective Synthesis of a Linker for Bioconjugation with a Peptide and a Monoclonal Antibody

Javier Magano; Brian G. Conway; Douglas Farrand; Michael Lovdahl; Mark T. Maloney; Mark J. Pozzo; John J. Teixeira; John Rizzo; David Tumelty

doi:10.1055/s-0033-1340980

Synthesis, Inhaltsverzeichnis

Synthesis 2014; 46(10): 1399-1406
DOI: 10.1055/s-0033-1340980

paper

Scalable and Cost-Effective Synthesis of a Linker for Bioconjugation with a Peptide and a Monoclonal Antibody

Authors

Javier Magano*

^aChemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, CT 06340, USA Fax: +1(860)7158593 eMail: Javier.Magano@Pfizer.com
Brian G. Conway

^aChemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, CT 06340, USA Fax: +1(860)7158593 eMail: Javier.Magano@Pfizer.com
Douglas Farrand

^bAnalytical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, CT 06340, USA
Michael Lovdahl

^bAnalytical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, CT 06340, USA
Mark T. Maloney

^aChemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, CT 06340, USA Fax: +1(860)7158593 eMail: Javier.Magano@Pfizer.com
Mark J. Pozzo

^cBiotherapeutics Pharmaceutical Sciences, Pfizer Worldwide Research & Development, 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA
John J. Teixeira

^aChemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, CT 06340, USA Fax: +1(860)7158593 eMail: Javier.Magano@Pfizer.com
John Rizzo

^dCovX Research, 9381 Judicial Drive, San Diego, CA 92121, USA
David Tumelty

^dCovX Research, 9381 Judicial Drive, San Diego, CA 92121, USA

Abstract

Alle Artikel dieser Rubrik

Abstract

An efficient, scalable, and cost-effective synthesis of a linker employed in a bioconjugation process with a peptide and a monoclonal antibody is presented. Several routes were investigated that resulted in the identification of a short synthesis to a key acid intermediate from inexpensive and readily available starting materials. The final coupling of this acid with an aniline to afford the desired linker has been optimized to produce multi-gram quantities of material for clinical studies. The very limited purifications needed for both intermediates and final product make this route amenable to scale.

Key words

linker - bioconjugation - peptide - monoclonal antibody - imide - azetidinone

Volltext

Referenzen

References
1 Hermanson GT. Bioconjugate Techniques . 2nd ed. Academic Press; San Diego: 2008
2 Veronese FM, Morpurgo M. Farmaco 1999; 54: 497
3 Le Sann C. Nat. Prod. Rep. 2006; 23: 357

4a Hermentin P, Seiler FR. Behring Inst. Mitt. 1988; 82: 197
4b Hermentin P, Doenges R, Gronski P, Bosslet K, Kraemer HP, Hoffmann D, Zilg H, Streinstraesser A, Schwartz A, Kuhlmann L, Lüben G, Seuler FR. Bioconjugate Chem. 1990; 1: 100

5a Pang Y, Liu J, Wu J, Li G, Wang R, Su Y, He P, Zhu X, Yan D, Zhu B. Bioconjugate Chem. 2010; 21: 2093
5b Voit BI, Lederer A. Chem. Rev. 2009; 109: 5924
5c Carlmark A, Hawker C, Hult A, Malkoch M. Chem. Soc. Rev. 2009; 38: 352
5d Saha A, Ramakrishnan S. Macromolecules 2008; 41: 5658
5e Gao C, Yan DY. Prog. Polym. Sci. 2004; 29: 183
5f Tomalia DA, Fréchet JM. J. J. Polym. Sci., Part A: Polym. Chem. 2002; 40: 2719
5g Bosman AW, Janssen HM, Meijer EW. Chem. Rev. 1999; 99: 1665

6 Bradshaw C, Sakamuri S, Fu Y, Oates B, Desharnais J, Tumelty D. Patent WO 2008081418 A1 20080710, 2008 ; Chem. Abstr. 2008, 149, 168435.
7 Acid 4 was purchased from Quanta Biodesign Limited at a cost of $ 750/g

8a Kasagi N, Kojima M, Hirai H. Japanese Patent JP 2007277130 A 20071025, 2007 ; Chem. Abstr. 2007, 147, 474626.
8b Li H, Guan Y, Szczepanska A, Moreno-Vargas AJ, Carmona AT, Robina I, Lewis GK, Wang L.-X. Bioorg. Med. Chem. 2007; 15: 4220

9a Ishino T, Palanki MS. S, Violand BN, Das TK, Hodge TS, Levin NJ, Parsons EK. Patent WO 2012/059873 A2, 2012 ; Chem. Abstr. 2012, 156, 628793.
9b Annathur GV, Balu P, Finn RF, Huang J, Laurent OA, Levin NJ, Luksha NG, Martin JP. Jr, Moskowitz H, Palanki MS. S, Pozzo MJ, Waszak GA, Xie J. Patent WO 2013/093720 A2, 2013 ; Chem. Abstr. 2013, 159, 159296.

10 During the preparation of this manuscript, a synthesis of linker 1 has been reported from acid 6 and amine 7 (Scheme 11). However, no experimental details, yields, or information on reaction scale were included. See: Palanki MS. S, Bhat A, Lappe RW, Liu B, Oates B, Rizzo J, Stankovic N, Bradshaw C. Bioorg. Med. Chem. Lett. 2012; 22: 4249
11 For the large-scale preparation of aniline 5·HCl, see: Magano J, Bock B, Brennan J, Farrand D, Lovdahl M, Maloney MT, Nadkarni D, Oliver WK, Pozzo MJ, Teixeira JJ, Wang J, Rizzo J, Tumelty D. Org. Process Res. Dev. 2014; 18: 142
12 Mantovani G, Lecolley F, Tao L, Haddleton DM, Clerx J, Cornelissen JJ. L. M, Velonia K. J. Am. Chem. Soc. 2005; 127: 2966
13 Brennauer A, Keller M, Freund M, Bernhardt G, Buschauer A. Tetrahedron Lett. 2007; 48: 6996

14a Reddy DS, Vander Velde D, Aubé J. J. Org. Chem. 2004; 69: 1716
14b Hashimoto M, Yang J, Holman GD. ChemBioChem 2001; 2: 52

15 Leach SG, Cordier CJ, Morton D, McKiernan GJ, Warriner S, Nelson A. J. Org. Chem. 2008; 73: 2753

16a Cooney MJ, Halton B. Aust. J. Chem. 1996; 49: 533
16b Juhász L, Docsa T, Brunyászki A, Gergely P, Antus S. Bioorg. Med. Chem. 2007; 15: 4048

17a Kim I.-H, Morisseau C, Watanabe T, Hammock BD. J. Med. Chem. 2004; 47: 2110
17b Tachibana K, Imaoka I, Yoshino H, Kato N, Nakamura M, Ohta M, Kawata H, Taniguchi K, Ishikura N, Nagamuta M, Onuma E, Sato H. Bioorg. Med. Chem. Lett. 2007; 17: 5573

18 Bird CW, Butler HI, Coffee EC. J, James LM, Schmidl BW. C. Tetrahedron 1989; 45: 5655
19 Monge S, Sélambarom J, Roque JP, Pavia AA. Tetrahedron 2001; 57: 9979
20 Philippon A, Degueil-Castaing M, Beckwith AL, Maillard B. J. Org. Chem. 1998; 63: 6814
21 Douelle F, Capes AS, Greaney MF. Org. Lett. 2007; 9: 1931

22a Katoh A, Kudo H, Saito R. Heterocycles 2005; 66: 285
22b Lown JW, Koganty RR, Joshua AV. J. Org. Chem. 1982; 47: 2027

23a Wosnick JH, Mello CM, Swager TM. J. Am. Chem. Soc. 2005; 127: 3400
23b Tomita H. Japanese Patent JP 2006327984 A 20061207, 2006 ; Chem. Abstr. 2007, 146, 45865.

24 Miller RJ, Kuliopulos A, Coward JK. J. Org. Chem. 1989; 54: 3436
25 Houghton RP, Southby DT. Synth. Commun. 1989; 19: 3199
26 Visintin C, Aliev AE, Riddall D, Baker D, Okuyama M, Hoi PM, Hiley R, Selwood DL. Org. Lett. 2005; 7: 1699
27 Dupraz A, Guy P, Dupuy C. Tetrahedron Lett. 1996; 37: 1237
28 Zhou M, Ghosh I. Org. Lett. 2004; 6: 3561
29 Milgrom LR, O’Neill F. Tetrahedron 1995; 51: 2137
30 Menger FM, Bian J, Seredyuk VA. Angew. Chem. Int. Ed. 2004; 43: 1265
31 Lee KJ, Mao S, Sun C, Gao C, Blixt O, Arrues S, Hom LG, Kaufmann GF, Hoffman TZ, Coyle AR, Paulson J, Felding-Habermann B, Janda KD. J. Am. Chem. Soc. 2002; 124: 12439
32 Paterson MJ, Eggleston IM. Synth. Commun. 2008; 38: 303

Zusatzmaterial

Supporting Information (PDF)